Tus kws kho mob
2024 September Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1091 - 1100 ntawm 3684
Tus kws kho mob
QP65-24 PCA Agency Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 28, 2024
Tus kws kho mob
QP66-24 Reminder: Patient Complaint Policy and Process Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 28, 2024
Tus kws kho mob
P49-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Radiation Oncology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
QP63-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2024
Tus kws kho mob
QP55R2-23 Change in Processing for Replacement Claims
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 24, 2024
Tus kws kho mob
QP54-24 MHCP Pharmacy Benefit Exclusion for DefenCath®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 10, 2024
Tus kws kho mob
P53-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024